Cytohesins are small guanine nucleotide exchange factors that stimulate ADP ribosylation factors, Ras-like GTPases, which control various cellular regulatory networks ranging from vesicle trafficking to integrin activation. A small molecule SecinH3 (1,2,4-triazole derivative) in an aptamer displacement assay as a pan-cytohesin Sec7-domain inhibitor was previously identified. Here a series of different SecinH3-analogues was designed and synthesised as potential cytohesin Sec7-domain inhibitors. All final synthesized compounds 6-8, 43-58 and their intermediates were confirmed by 1 H NMR,
Cytohesins are small (ca. 45 kD) guanine nucleotide exchange factors (GEFs) that stimulate ADP ribosylation factors, or ARFs, which represent ubiquitously expressed Ras-like GTPases [1] [2] [3] . The most widely studied cytohesin-dependent ARF members are ARF1 and ARF6. These ARFs, and thereby also the cytohesins as their activators, control various cellular regulatory networks ranging from vesicle trafficking, remodeling of the actin cytoskeleton, or cell adhesion to integrin activation [4] . Four highly related cytohesin homologs are known in mammals: cytohesin 1, cytohesin 2, cytohesin 3, and cytohesin 4. Cytohesins are multi-domain proteins, and all of them consist of an N-terminal coiled coil domain, a Sec7 domain that harbours the GEF activity, a Pleckstrin homology (PH) domain, and a C-terminal polybasic domain fig.1 .
A related class of ARF-GEFs that also contain a Sec7-domain are the members of the large (i.e. ca. 200 kD) GEF-family, such as the human BIG1 and BIG2, or the yeast Gea2 [5] [6] [7] . The fungal metabolite brefeldin A (BFA), which selectively inhibits guanine nucleotide exchange of the large Sec7 GEFs on ARFs, but not of the small cytohesin GEF members, has established itself as a tremendously useful chemical biology tool for elucidating the biological function of the large GEFs.
To obtain selective inhibitors for the small GEFs of the cytohesin family, we have previously selected an RNA aptamer (M69) that binds to the Sec7 domain of cytohesins. M69 discriminates between large and small GEFs, but it binds with similar affinity to cytohesins 1, 2, and 3. When expressed as an intramer in the cytoplasm of Jurkat cells, M69 allowed implicating cytohesin GEF activity in actin cytoskeletal reorganization [8] . However, while the use of intramers in cell culture is straightforward, their application in whole organisms is hampered by their instability, bioavailability, and transmembrane delivery, at least when targeting intracellular proteins [9] [10] [11] . Thus, the development of therapeutic aptamers that target intracellular target is a process that faces complications usually associated with the nucleic acid-based drugs [12] .
To cope with these limitations, we have established aptamer displacement assays [13] [14] [15] . And aptamerregulated allosteric ribozymes [16] [17] [18] [19] to screen for small drug-like molecules with similar inhibitory profile as the parent aptamers. For identifying a small molecule cytohesin antagonist, we have used a 5'-fluorescein-labeled version of the aptamer Research Paper M69 [20] . The screening assay was based on aptamer displacement, followed by fluorescence polarization. We identified the 1,2,4-triazole derivative 1, called SecinH3 (Scheme 1), which bound to the Sec7-domain of cytohesins and inhibited guanine nucleotide exchange on ARF1 and ARF6, respectively [21] . The binding to cytohesins is highly specific [22] and its IC 50 value for the GEF activity of the cytohesin-1 Sec7 domain on D17-ARF1 was determined to be 10-11 µM [23] . When applied in human liver cells, flies, and mice, SecinH3 allowed implicating insulin receptor complexassociated cytohesins as essential for proper insulin signaling [21, 24] . SecinH3 is now widely used in biological assays as either a cytohesin antagonist or as an indirect Arf6 inhibitor [25] [26] [27] [28] [29] [30] [31] [32] [33] .
Herein we report the rational design, and synthesis of a novel series of derivatives that are derived from the SecinH3 scaffold, in which different core elements of SecinH3 were systematically altered ( fig. 2 ).
MATERIALS AND METHODS
All the chemicals used were of analytical grade and purified by standard methods prior to use. The Melting points were measured using a Stuart Scientific melting point apparatus SMP3 (UK) and are uncorrected. The NMR spectra were taken using Bruker DPX 300 MHz instrument at Organic Chemistry institute, Bonn, Germany. DMSO-d 6 was used as solvent and the chemical shifts are given in δ (ppm) values. The chemical shifts of the remaining protons of the deuterated solvent served as internal standard: δ 1 H: 2.49 ppm, 13 C: 39.7 ppm. The EI-MS was obtained using EI-Finnigan MAT 95XL (Thermo Finnigan, Bremen) and FAB-MS was obtained using Concept 1H (Kratos, Hofheim), with m-Nitrobenzyl alcohol as matrix. Silica gel column chromatography was carried out using kieselgel 60 (Merck). TLC analysis was performed on kieselgel 60 F 254 (Merck) aluminum plates.
2-(4-Hydroxyphenylthio)acetic acid, 2-(3,4-dihydro-2,4-dioxopyrimdin-1(H)-yl)acetic acid and 2-(3,4-dihydro-5-methyl-2,4-dioxopyrimdin-1-(H)-yl) acetic acid were prepared as described according to the reported procedure [34, 35] . These derivatives were synthesized as illustrated in Schemes 1 and 2.
Synthesis of O-methyl-N-acyl-thiocarbamate and O-ethyl-N-acyl-thiocarbamate derivatives (3, 19-26):
To a solution of acid chloride derivative (1, 17a-e) (37,84 mmol) in acetone (60 ml), potassium thiocyanate (3.68 g, 37.84 mmol, 1.0 eq.) under efficient stirring. The reaction mixture was refluxed at 60° for 60-120 min and monitored using TLC until the start is completely disappeared. Ethanol or methanol (94.60 mmol, 2.5 eq.) was added drop wise and the reaction mixture was refluxed for 4-7 h and then cooled, filtered, washed with acetone (15 ml). The filtrate was evaporated and the residue was purified either by silica gel chromatography if it is oil or by crystallization if it is solid to afford the desired product. Yield (74-94%).
The molecular characteristics of O-methyl-N-(benzoyl) thiocarbamate 19 as representative example for this series are as follow, (300 MHz, CDCl 3 ): δ 9.16 (br, 1H), 7.75 (m, 2H), 7.51 (m, 1H), 7.42 (m, 2H), (20 ml) . Concentrated HCl (0.25 ml) was added to the above reaction mixture and was heated at 65° for 3 h. The reaction mixture was filtered when hot and was washed several times with hot methanol (8×15 ml). The filtrate was evaporated to remove methanol and the precipitated product was filtered and washed with cold water. The crude product was purified by silica gel chromatography to afford the product as pale white solid. Yield obtained was 35-43%.
(s, 3H
In the method B, to a suspension of the nitro derivative 4, 27-34 (7.61 mmol) in ethanol (70 ml), (Pd/C10% 2.87 g) was added portion wise after washing with argon gas three times. The reaction mixture was transferred into autoclave under H 2 atmosphere and 20 bar pressure and stirred overnight. The reaction mixture was filtered through celite pad and was washed with ethanol (120 ml) and then hot methanol (5×120 ml). The solvent was concentrated and the rest was cooled in the refrigerator to afford the amine product (5, 35- 
phenylthio)-acetamide 6 was synthesized by adding to a solution of 5 (1.277 g, 4.12 mmol, 1 eq.) and triethyl amine (1.14 ml, 8.22 mmol, 2 eq.) in dichloroethane (20 ml) and phenylthioacetyl chloride (0.61 ml, 4.11 mmol, 1 eq.). The reaction mixture was stirred overnight at room temperature (RT) and was diluted with dichloromethane (100 ml). The reaction mixture was washed with 5% aqueous Na 2 CO 3 solution (25 ml) and water (2×50 ml), respectively. The organic phase was dried over MgSO 4 , filtered and evaporated to dryness. The crude product was purified by silica gel chromatography using ethylactate/cyclohexane (1:1) as eluent system to give the product as pale white foam. Yield obtained was 67%, mp 202-204°. and DMAP (0.09 g, 0.74 mmol) in DCM (10 ml) and DMF (6 ml), the triazole amine derivative 5 (0.7 g, 2.26 mmol). After the reaction mixture was stirred at RT overnight, the solvent was evaporated under reduced pressure. The crude product was purified by silica gel chromatography using (cyclohexane/ ethylacetate 1:1) as eluent system to give the product as white powder. Yield obtained was 0.32 g, (31%) and the mp was 212-214°. 
-(phenyl-sulfonyl)acetamide 8 was prepared by adding to a stirred solution of 6 (117 mg, 0.254 mmol) in DCM (5 ml), a solution of peracetic acid (39% in AcOH, 175 mg, 1.07 mmol). The reaction mixture was stirred for 7 h before being extracted with DCM (30 ml) and water (30 ml). The organic phase was washed with water (2×25 ml) and the combined aqueous phases were extracted with DCM (50 ml). The combined organic phases were dried over MgSO 4 and evaporated in vacuo to yield the product as white powder, which purified by column chromatography using ethylactate/ cyclohexane (1:1) as eluent system. Yield obtained was 0.105 mg (84%) with an mp of 217-219°. 
acetamide 9 was sythesised as follows. To a solution of (2-pyridylthio)acetic acid (0.55 g, 3.2 mmol), EDC (0.617 g, 3.2 mmol) and DMAP (0.12 g, 0.99 mmol) in DCM (10 ml) and DMF (5 ml) under argon atmosphere, the amine 5 (1.0 g, 3.2 mmol) was added. The reaction mixture was stirred at RT overnight and the solvent was evaporated under reduced pressure. The crude product was purified by silica gel chromatography using 3-7% MeOH/DCM to give the desired product with an yield of 51 % (0.76 g) and mp 176-178°. 
dioxopyrimidin-1(2H)-yl acetamide 11 was prepared using the following procedure. Thymine-1-acetic acid (0.30 g, 1.61 mmol, EDC (0.31 g, 1.61mmol) and DMAP (0.037 g, 0.31 mmol) were dissolved in 10 ml DMF under argon atmosphere. To the reaction mixture the amine 5 (0.5 g, 1.61 mmol) in DCM (10 ml) was added and the reaction was further stirred overnight at RT The solvent was evaporated under reduced pressure. The crude product was purified by silica gel chromatography using DCM/MeOH (9:1) as eluent system to give the product as white powder. Yield obtained was (25 g 
To a solution of 3-thiopheneacetic acid (0.23 g, 1.6 mmol, EDC (0.309 g, 1.6 mmol) and DMAP (0.06 g, 0.50 mmol) in DCM (10 ml) and DMF (3 ml) under argon atmosphere, the amine 5 (0.5 g, 1.6 mmol) was added. The reaction mixture was stirred at RT overnight and then the solvent was evaporated under reduced pressure. The crude product was purified by silica gel chromatography using cyclohexane/ethylacetate (1:2) as eluent to give the product as white crystals. Yield was 0.22 g (31.4%) and mp was 213-215°. 
To a solution of 2-pyridylacetic acid hydrochloride (0.39 g, 2.26 mmol, EDC (0.44 g, 2.26 mmol), TEA (0.6 ml, 4.54 mmol) and DMAP (0.09 g, 0.74 mmol) in DCM (20 ml) under argon atmosphere, the amine 5 (7.0 g, 2.26 mmol) was added. The reaction mixture was stirred at RT overnight and then the solvent was evaporated under reduced pressure. The crude product was purified by silica gel chromatography using DCM/MeOH (3-6%) as eluent to give the product as white crystals. Yield was 0.61 g (62%) and the mp was 180-182°. 1 To a solution of imidazole-4-acetic acid hydrochloride (0.185 g, 1.13 mmol, EDC (0.22 g, 1.13 mmol) and DMAP (0.045g, 0.37 mmol) in DCM (5 ml) and DMF (10 ml) under argon atmosphere, the amine 5 (0.35 g, 1.13 mmol) was added. The reaction mixture was stirred overnight at RT and the solvent was evaporated under reduced pressure. The crude product was purified by silica gel chromatography using MeOH/ DCM (5-8%) to give the desired product. Yield obtained was 0.15 g (28%) and the mp was 196-198°.
6.87- 6.94 (m, 3H), 6.05 (s, 2H), 3.91 (s, 3H) 05 mmol, 1 eq.) and triethyl amine (0.57 ml, 4.10 mmol, 2 eq.) in DCM (15 ml) was added phenylthioacetyl chloride (0.3 ml, 2.06 mmol, 1 eq.). The reaction mixture was stirred overnight at RT. Phenylthioacetyl chloride (0.1 ml, 0.67 mmol) was added and then reaction was refluxed for 3 h. The reaction mixture was diluted with dichloromethane (50 ml) and the reaction mixture was washed with 5% aq. Na 2 CO 3 solution (25 ml) and water (2×50 ml), respectively. The organic phase was dried over MgSO 4 and then filtered and evaporated to dryness. The crude product was purified by silica gel chromatography using cyclohexane: EtOAc (3:2) as eluent to give the product as white crystals. Yield, (0.38 g, 44 %), mp 120-122°. (m, 10H), 3.98 (s, 3H), 3.70 (s, 2H) . 13 01 mmol, 1 eq.) and triethyl amine (0.28 ml, 2.01 mmol, 2 eq.) in DCM (10 ml) was added phenylthioacetyl chloride (0.15 ml, 1.01 mmol, 1 eq.). The reaction mixture was stirred overnight at room temperature, 0.15 ml of phenylthioacetyl chloride was added and then the reaction was stirred at 55° for 3 h. The reaction mixture was diluted with dichloromethane (70 ml). The reaction mixture was washed with 5% aquous Na 2 CO 3 solution (15 ml) and water (2×25 ml), respectively. The organic phase was dried over MgSO 4 , filtered and evaporated to dryness. The crude product was purified by silica gel chromatography to give the product as pale white foam like crystals with a yield of 0.2 g (46%) and mp of 122-124°. (m, 1H), 7.23-7.28 (m, 3H) 7.11-7.19 (m, 5H) N-(4-(5-(2-Fluorophenyl)-3-methoxy-1H-1,2,4-triazol-1-yl)phenyl)-2-(3,4-dihydro-5-methyl-2-4-dioxopyrimidin-1(2H)-yl))acetamide 46. Thymine-1-acetic acid (0.32 g, 1.76 mmol, EDC (0.33 g, 1.76 mmol) and DMAP (0.050 g, 0.42 mmol) were dissolved in 10 ml DMF under argon atmosphere. To the reaction mixture the amine 36 (0.5 g, 1.76 mmol) in DCM (10 ml) was added and the reaction was further stirred overnight at RT. The solvent was evaporated under reduced pressure. The crude product was purified by silica gel chromatography with DCM/ MeOH (9:1) as eluent system and then crystallized from ethanol to give the product as white crystals. Yield was 0.42 g (53%) and mp was 200-202°. N-(4-(5-(2-Fluorophenyl)-3-methoxy-1H-1,2,4-triazol-1-yl)phenyl)-2-(3,4-dihydro-2-4-dioxo-pyrimidin-1(2H)-yl))acetamide 47 was synthesized by the same procedure of 46 using uracil-1-acetic acid instead of thymine-1-acetic acid to give the product as white crystals. Yield was 0.27 g (35.1%) and mp was 238-240°. N-(4- (5-(2,5-Difluorophenyl)-3-methoxy-1H-1,2,4 N-(4-(3-Ethoxy-5-(2-fluorophenyl)-1H-1,2,4-triazol-1-yl)phenyl)-2-(3,4-dihydro-5-methyl-2-4-dioxopyrimidin-1(2H)-yl))acetamide 50. Thymine-1-acetic acid (0.31 g, 1.68 mmol, EDC (0.32 g, 1.68 mmol) and DMAP (0.050 g, 0.42 mmol) were dissolved in 10 ml DMF under argon atmosphere. To the reaction mixture the amine 39 (0.5 g, 1.68 mmol) in DCM (10 ml) was added and the reaction was further stirred overnight at room temperature. The solvent was evaporated under reduced pressure. The crude product was purified by silica gel chromatography (DCM/MeOH, 9:1) as eluent system and then crystallized from ethanol to give the product as white powder with a yield of 0.41 g (52%) and mp of 241-243°. N-(4-(5-(4-tert-Butylphenyl)-3-methoxy-1H-1,2,4-triazol-1-yl)phenyl)-2-(3,4-dihydro-5-methyl-2-4-dioxopyrimidin-1(2H)-yl))acetamide 53. Thymine-1-acetic acid (0.29 g, 1.55 mmol, EDC (0.30 g, 1.55 mmol) and DMAP (0.037 g, 0.31 mmol) were dissolved in 10 ml DMF under argon atmosphere. To the reaction mixture the amine 41 (0.5 g, 1.55 mmol) in DCM (10 ml) was added and the reaction was further stirred overnight at RT. The solvent was evaporated under reduced pressure. The crude product was purified by silica gel chromatography (DCM/MeOH, 9:1) as eluent system to give the product as white powder. Yield, (0.24 g, 32%), mp 225-227°. 139.57, 133.51, 128.53, 127.23, 125.88, 124.98 N-(4-(5-(3-Fluorophenyl)-3-methoxy-1H-1,2,4-triazol-1-yl)phenyl)-2-(thiophen-2-yl)-acetamide 55 was prepared as follows. To a solution of amine 42 (0.265 g, 0.84 mmol, 1 eq.) and triethyl amine (0.24 ml, 1.68 mmol, 2 eq.) in DCM (15 ml) was added thiophene-2-acetylchloride (0.135 g, 0.105 ml, 0.84 mmol, 1 eq.). The reaction mixture was stirred overnight at RT. The reaction mixture was diluted with dichloromethane (40 ml), washed with 5% aq. Na 2 CO 3 solution (15 ml) and water (220 ml), respectively. The organic phase was dried over MgSO 4 , filtered and evaporated to dryness. The crude product was purified by silica gel chromatography using cyclohexane: EtOAc (1:1) and then repurified using another eluent system of cyclohexane: EtOAc (2:3) to afford the pure target product with a yield of 0.1 g (23%) and mp 153-155°. 25 (m, 6H), 6.96-7.03 (m, 3H) N-(4-(5-(2,5-Difluorophenyl)-3-methoxy-1H-1,2,4-triazol-1-yl)phenyl)-2-(thiophen-2-yl)-acetamide 57. To a solution of amine 37 (0.61 g, 2.01 mmol, 1 eq.) and triethyl amine (0.56 ml, 4.02 mmol, 2 eq.) in dichloromethane (15 ml) was added thiophene-2-acetylchloride (0.323 g, 0.25 ml, 2.01 mmol, 1 eq.). The reaction mixture was stirred overnight at RT. The reaction mixture was diluted with dichloromethane (40 ml), washed with 5% aq. Na 2 CO 3 solution (15 ml) and water (2×20 ml), respectively. The organic phase was dried over MgSO 4 , filtered and evaporated to dryness. The crude product was purified by silica gel chromatography (cyclohexane: EtOAc, 1:1) two times to give the pure product. Yield: (0.26 g, 30%), mp 172-174°. 
Exchange assay of hCyt1-Sec7:
[D17]ARF1 and ARNO-Sec-7 were subcloned into pET15 vectors (Novagen) as described previously [13, [21] [22] [23] 36] . N-Terminal truncated [D17]ARF1 (amino acids 18-181), lacking the first 17 amino acids and cytohesin-1-Sec-7 were expressed in Escherichia coli and purified by Ni-NTA chromatography (Ni-NTA agarose, Quiagen). GDP/GTP exchange was measured on [D17]ARF1 by tryptophan fluorescence because a large increase in intrinsic fluorescence of ARF occurs upon exchange of GDP for GTP [34, 37] . All measurements were performed in PBS pH 7. 
IGFBP1 gene expression:
HepG2 cells (ECACC) 10 5 were seeded in 12 well plates and cultured for 24 h in EMEM (Cambrex) containing 10% FCS. Cells were then serum starved in EMEM for 24 h and stimulated for 12 h with 10 nM insulin in the presence of the inhibitor SecinH3 or control, with 0.8% final concentration of DMSO. Total mRNA was prepared using the Absolutely RNA Kit (Stratagene) and cDNA for qPCR was generated from 1 µg RNA with the High Capacity cDNA Archive Kit (Applied Biosystems). qPCR was performed in a 10 µl scale on an iQ5-cycler (BioRad) using a TaqMan Gene Expression Assay for IGFBP1 (Applied Biosystems). Data were normalized to b2-microglobulin expression.
RESULTS AND DISCUSSION
The design and synthesis of the new SecinH3 derivatives 6-15 and 43-58 is based on the change of the substitutions at three points as illustrated in fig. 2 . These derivatives were synthesized as illustrated in Schemes 1 and 2. In this group of compounds in scheme 1 the blue part of SecinH3 was changed ( fig. 2 ) taking in mind the importance of sulfur and the aryl moiety. Firstly p-OH was introduced to the phenyl moiety in compound 8 and 54 to increase the polarity and consequently the water solubility and for the same reason sulfur was oxidized the to sulfonyl group in compound 8 and 54. Trials to investigate if the phenyl group could be changed by other heterocyclic rings such as imidazole, pyridine, thiophene, uracil and thymine as aromatic bioisoester groups with retained activity of SecinH3. Finally, the sulfur bridge was also changed to investigate if it must be exocyclic or could be included in heterocyclic rings or not essential at all. From these changes the structure activity relationship (SAR) of SecinH3 could be studied.
The second group of compounds Scheme 2 represents the change and study of structure activity relationship (SAR) of SecinH3 by changing both red part and green parts. The green part was modified within 2-3 carbons according our pervious study that small substituents such as methyl, ethyl and propyl could be tolerated at this position. The third point of design is the change of pipronyloyl moiety (red part) by phenyl group carrying electron attracting groups at different positions of the ring to investigate the effect of these groups on the biologicall activity of the SecinH3.
The intermediates, 2-(4-Hydroxyphenylthio)acetic acid, 2-(3,4-dihydro-2,4-dioxopyrimdin-1(H)-yl)acetic acid and 2-(3,4-dihydro-5-methyl-2,4-dioxopyrimdin-1-(H)-yl)acetic acid were prepared as described according to the reported procedure [36, 37] .
The compounds 3 and 19-26 were prepared by reaction of acid chloride derivatives 1 and 17a-e with KSCN and the respective alcohols as illustrated in schemes 1-2. These derivatives were confirmed using 1 H-NMR, 13 C-NMR, FAB-MS, EI-MS and HRMS (see exp. Part). Their 1 H-NMR spectra were characterized by appearance of amidic NH around δ 9-9.6 ppm and the introduced methyl, ethyl or isopropyl moities and 13 C-NMR spetra showed C=O group ranged from δ 180 to 189 ppm and C=S group ranged from δ 160 to 164 ppm. HRMS 4-(5-(un)substituted phenyl)-3-alkyl-1H-1,2,4-triazol-1-yl)phenyl amine derivatives 5, 35-42 were prepared by reduction of nitro derivatives 4, 27-34, respectively. The reduction process was achieved using two methods of reduction: i. Chemical reduction using ammonium chloride and iron in methanol and water, followed by purification using silica gel chromatography to afford the product as pale white solid. The problems of this method are the low yield (40-50%) and its awful efforts in purification. ii. Catalytic reduction method using palladium as catalyst under hydrogen atmosphere and 20 bar pressure using autoclave. The advantages of the second method are higher yield (70-80%), easier purification and more convenient procedure. The latter method enables us to make multigram scaling synthesis of final derivatives especially compound 6 for further biological investigations. These amine derivatives 5, 35-42 were proved by different spectral data The final compounds 6-15 and 43-58 were synthesized either by condensation of amine derivatives with the respected acid chloride in dichloromethane and triethylamine as catalyst under argon atmosphere or with the respected carboxylic acid derivative in presence of condensing agent such as EDC and DMAP in dimethylformamide under argon atmosphere.
1 H-NMR spectra of these derivatives were characterized by disappearance of the signal corresponding to NH 2 and appearance of downfield signal (1H) corresponding to amidic NH and signals corresponding to introduced moiety. In addition, 13 C-NMR spectra showed amidic + (3rd batch). Sulfonyl compounds 8 and 54 were prepared by oxidation of compounds 6 and 49, respectively using peracetic acid (39% in AcOH) [36] and then purified by column chromatography. The 1 H-NMR spetra of these derivatives showed downfieldshift of CH2-SO2-if compared to CH2-Sand further conformed by HRMS for example compound 8 (m/z): calcd. for C 24 Preliminary biological screening of the target compounds indictaed that some of the new synthesized secinH3 derivatives showed higher potency and promising activity more than secinH3 itself (detalied study is still in progress). For example compund 9 and 10 were approximate equal to secinH3 activity as cytohesin antagonist activity. Furthermore compound 52 showed twice inhibition potency if compared to secinH3. Detailed biological screening and study of the structure activity relationship (SAR) of SecinH3 new derivatives is in progress.
In conclusion, rational design, synthesis of novel SecinH3 derivatives as potential cytohesin inhibitors is reported here. Final compounds were synthesized as shown in Schemes 1-2 starting with benzo [1, 3] dioxole-5-carbonyl-chloride or different benzoyl chloride derivatives and potassiumisothiocyanate (KNCS). The 1,2,4-triazol ring was readily assembled from benzo [1, 3] dioxole-5-carbonylisothiocyanate in two steps, using (4-nithrophenyl)-hydrazine as previously described and then further elaborated after reduction using the appropriate substituted acetic acid derivative to yield the desired compounds in the presence of HBTU in DMF. Detailed biological screening of these new derivatives is in progress.
